{"id":456181,"date":"2021-03-11T11:59:07","date_gmt":"2021-03-11T16:59:07","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=456181"},"modified":"2021-03-11T11:59:07","modified_gmt":"2021-03-11T16:59:07","slug":"novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/","title":{"rendered":"Novozymes acquires data science platform of Biota to strengthen microbiome R&amp;D capabilities in probiotic development"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <b>The acquisition of Biota\u2019s successful microbiome R&amp;D team and data science platform strengthens Novozymes\u2019 leading microbe innovation capability and will be a force-multiplier of the company\u2019s current probiotic development activities and recent acquisitions in the consumer health industry.<\/b>\n      <\/p>\n<p>\n        <b>COPENHAGEN, Denmark \u2013 Thursday 11 March 2021. <\/b>Today, Novozymes, the world leader in biological solutions, announced the acquisition of the microbiome R&amp;D team and data science platform of Biota. Based in San Diego, US, Biota pioneered industrial genomics using microbiome insights, impacting the economics and sustainability of several industrial sectors including energy, water, and manufacturing. As part of Novozymes, the R&amp;D team and data science platform will strengthen Novozymes\u2019 ability to discover and deliver beneficial microbes to the world with unique and scientifically proven health and sustainability benefits.<\/p>\n<ul>\n<li>\u201cThis acquisition fits well with our strategy, Better Business with Biology. Building on acquisitions we made last year within Human Health, we\u2019re strengthening our expertise and capabilities within microbiomes, ensuring we extract as much value from these acquisitions as possible. With this investment, we take another important step in implementing the strategy and setting a foundation of growth for our business,\u201d says Ester Baiget, President and CEO of Novozymes.<\/li>\n<\/ul>\n<p>\n        <b>Combining forces for a competitive edge<\/b><br \/>\n        <br \/>The addition of Biota\u2019s R&amp;D team and data science platform will give Novozymes a technical edge for pursuing new opportunities and further strengthen existing solutions in OneHealth, Novozymes\u2019 human health unit. Furthermore, the acquisition will act as a foundational enabler for many of its key industries, including Animal Health, BioAg and Household Care.<\/p>\n<ul>\n<li>\u201cUnderstanding micro-organisms and their role in shaping human, animal and plant health represents tremendous innovation opportunities for Novozymes,\u201d says Claus Crone Fuglsang, EVP and CSO of Novozymes and continues: <\/li>\n<li>\u201dThe experience of the R&amp;D team from Biota in translating complex microbiome and genomics data into biological insights and health benefits using their world-class data science platform will be key to advancing our leading probiotics pipeline as well as pursuing new opportunities for future growth.\u201d<\/li>\n<\/ul>\n<p>The acquisition will not only advance Novozymes\u2019 ability to discover new beneficial microbes, but also help prove the application performance of those microbes, for example through clinical trials, for the benefit of people, animals and farmers. <\/p>\n<p>The inclusion of Biota\u2019s microbiome analysis software and R&amp;D team into these activities will accelerate and de-risk timelines, and ensure complete and efficient knowledge extraction from trials by bringing unique expertise, best-in-class data pipelines, AI methods and new ways of working into Novozymes.<\/p>\n<ul>\n<li>\u201cWe welcome Biota employees to Novozymes. With our unique expertise within discovery and Biota\u2019s strong R&amp;D capabilities and data science platform, we will be in a unique position. It\u2019s a position where we can develop new and scientifically-proven solutions and bring them quickly to the market,\u201d says Ester Baiget.<\/li>\n<li>\u201cThe acquisition by Novozymes, a global leader in industrial biotech, is a testament to Biota\u2019s innovations in data science and the compelling growth market for microbiome solutions. Since inception, Biota translated microbiome research from university into enterprise-grade diagnostics that resulted in measurable impact in both the economics and carbon footprint for several industrial customers.\u201d says Ajay Kshatriya, CEO at Biota and continues: <\/li>\n<li>\u201cLooking ahead, Biotans will continue to impact strategic decisions that improve the economics and sustainability of industrial processes. This acquisition marks the next exciting chapter in our pioneering work to commercialize Biology as a Data Business.\u201d<\/li>\n<\/ul>\n<p>Novozymes has acquired this data science platform for an undisclosed amount that is immaterial to Novozymes financials. Biota will retain a commercial license to apply the data science platform for genomic diagnostics. <\/p>\n<p>\n        <b><br \/>\n          <br \/> About Biota<\/b><br \/>\n        <br \/>Biota is the pioneer of industrial genomics with a vision to commercialize\u00a0<i>Biology as a Data Business<\/i>. Since 2014, Biota has delivered measurable impact to the economics and GHG footprint for customers in the energy, water, manufacturing, and mining industries. Biotans discovered foundational innovations in microbiome measurement and implemented innovative, enterprise-grade AI software for clients worldwide. Biota provides genomic monitoring solutions that impact strategic decisions with improved ROIC, increased operating margin, and reduced risk. <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=W1vOe5Y-UL2dELbtWwAUidOvW2On1CAJlTXGD5Kp71l71lb-4McWQdmp_OMGTN-i7CqN5O4gix7yUlgy5kEQfA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.biota.com<\/u><\/a><\/p>\n<p>\n        <b>About Novozymes <br \/><\/b>Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet&#8217;s resources and helping build better lives. As the world&#8217;s largest provider of enzyme and microbial technologies, our bio innovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel, and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=W1vOe5Y-UL2dELbtWwAUiX4dECx8kp4TlrSHoZWSm4X2pIjmlbCiyyXXgGNnGVaLTWbbt8qFbR4xXd2vCILCN21CumHaFnnbGhiM_GdjV4Q=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.novozymes.com<\/u><\/a><\/p>\n<p> NASDAQ OMX: NZYM-B \u2022 6,500 employees \u2022 DKK 14,5 billion turnover \u2022 30+ industries \u2022 700+ products<\/p>\n<\/p>\n<table style=\"border-collapse: collapse;border-collapse:collapse\">\n<tr>\n<td style=\"width:205.34px;vertical-align: top\">\n            <b>\u00a0<\/b>\n          <\/td>\n<td style=\"width:205.40px;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:205.40px;vertical-align: top\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:205.34px;vertical-align: top\">\n            <b>Media Relations<\/b>\n          <\/td>\n<td style=\"width:205.40px;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:205.40px;vertical-align: top\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:205.34px;vertical-align: top\"> Lina Danstrup, <br \/> Head of Press Relations<br \/> Phone: +45 30 77 05 52<br \/><a href=\"mailto:likr@novozymes.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>likr<\/u><u>@novozymes.com<\/u><\/a><\/td>\n<td style=\"width:205.40px;vertical-align: top\"> Frederik Bj\u00f8rndal, <br \/> Head of Communications, <br \/>North America<br \/> Phone: +1 646 671 3897<br \/><a href=\"mailto:tfbh@novozymes.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>tfbh@novozymes.com<\/u><\/a>\u00a0\u00a0   <\/td>\n<td style=\"width:205.40px;vertical-align: top\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:205.34px;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:205.40px;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:205.40px;vertical-align: top\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:205.34px;vertical-align: top\">\n            <b>Investor Relations<\/b>\n          <\/td>\n<td style=\"width:205.40px;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:205.40px;vertical-align: top\"> \u00a0 <\/td>\n<\/tr>\n<tr>\n<td style=\"width:205.34px;vertical-align: top\"> Tobias Cornelius Bj\u00f6rklund<br \/> Phone: +45 30 77 86 82<br \/><a href=\"mailto:tobb@novozymes.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>tobb@novozymes.com<\/u><\/a><\/td>\n<td style=\"width:205.40px;vertical-align: top\"> \u00a0 <\/td>\n<td style=\"width:205.40px;vertical-align: top\"> \u00a0  <\/td>\n<\/tr>\n<\/table>\n<p id=\"gnw_attachments_section-header\">\n        <strong>Attachment<\/strong>\n      <\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n          <a target=\"_blank\" href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/2fd2fb7d-7b2d-4449-9338-5989c88a6792\" rel=\"noopener noreferrer\">11 MAR 2021_Novozymes acquieres data science platform by Biota_Press Release<\/a>\n        <\/li>\n<\/ul>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ2MTg0OSM0MDA4ODMxNTQjMjAwMjM5NA==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml-eu.globenewswire.com\/release\/track\/310473ac-60c5-4fe5-91b5-849ae1ca708d\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The acquisition of Biota\u2019s successful microbiome R&amp;D team and data science platform strengthens Novozymes\u2019 leading microbe innovation capability and will be a force-multiplier of the company\u2019s current probiotic development activities and recent acquisitions in the consumer health industry. COPENHAGEN, Denmark \u2013 Thursday 11 March 2021. Today, Novozymes, the world leader in biological solutions, announced the acquisition of the microbiome R&amp;D team and data science platform of Biota. Based in San Diego, US, Biota pioneered industrial genomics using microbiome insights, impacting the economics and sustainability of several industrial sectors including energy, water, and manufacturing. As part of Novozymes, the R&amp;D team and data science platform will strengthen Novozymes\u2019 ability to discover and deliver beneficial microbes to the world with unique and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Novozymes acquires data science platform of Biota to strengthen microbiome R&amp;D capabilities in probiotic development&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-456181","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novozymes acquires data science platform of Biota to strengthen microbiome R&amp;D capabilities in probiotic development - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novozymes acquires data science platform of Biota to strengthen microbiome R&amp;D capabilities in probiotic development - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"The acquisition of Biota\u2019s successful microbiome R&amp;D team and data science platform strengthens Novozymes\u2019 leading microbe innovation capability and will be a force-multiplier of the company\u2019s current probiotic development activities and recent acquisitions in the consumer health industry. COPENHAGEN, Denmark \u2013 Thursday 11 March 2021. Today, Novozymes, the world leader in biological solutions, announced the acquisition of the microbiome R&amp;D team and data science platform of Biota. Based in San Diego, US, Biota pioneered industrial genomics using microbiome insights, impacting the economics and sustainability of several industrial sectors including energy, water, and manufacturing. As part of Novozymes, the R&amp;D team and data science platform will strengthen Novozymes\u2019 ability to discover and deliver beneficial microbes to the world with unique and &hellip; Continue reading &quot;Novozymes acquires data science platform of Biota to strengthen microbiome R&amp;D capabilities in probiotic development&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-11T16:59:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ2MTg0OSM0MDA4ODMxNTQjMjAwMjM5NA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Novozymes acquires data science platform of Biota to strengthen microbiome R&amp;D capabilities in probiotic development\",\"datePublished\":\"2021-03-11T16:59:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\\\/\"},\"wordCount\":830,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ2MTg0OSM0MDA4ODMxNTQjMjAwMjM5NA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\\\/\",\"name\":\"Novozymes acquires data science platform of Biota to strengthen microbiome R&amp;D capabilities in probiotic development - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ2MTg0OSM0MDA4ODMxNTQjMjAwMjM5NA==\",\"datePublished\":\"2021-03-11T16:59:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ2MTg0OSM0MDA4ODMxNTQjMjAwMjM5NA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ2MTg0OSM0MDA4ODMxNTQjMjAwMjM5NA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novozymes acquires data science platform of Biota to strengthen microbiome R&amp;D capabilities in probiotic development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novozymes acquires data science platform of Biota to strengthen microbiome R&amp;D capabilities in probiotic development - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/","og_locale":"en_US","og_type":"article","og_title":"Novozymes acquires data science platform of Biota to strengthen microbiome R&amp;D capabilities in probiotic development - Market Newsdesk","og_description":"The acquisition of Biota\u2019s successful microbiome R&amp;D team and data science platform strengthens Novozymes\u2019 leading microbe innovation capability and will be a force-multiplier of the company\u2019s current probiotic development activities and recent acquisitions in the consumer health industry. COPENHAGEN, Denmark \u2013 Thursday 11 March 2021. Today, Novozymes, the world leader in biological solutions, announced the acquisition of the microbiome R&amp;D team and data science platform of Biota. Based in San Diego, US, Biota pioneered industrial genomics using microbiome insights, impacting the economics and sustainability of several industrial sectors including energy, water, and manufacturing. As part of Novozymes, the R&amp;D team and data science platform will strengthen Novozymes\u2019 ability to discover and deliver beneficial microbes to the world with unique and &hellip; Continue reading \"Novozymes acquires data science platform of Biota to strengthen microbiome R&amp;D capabilities in probiotic development\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-11T16:59:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ2MTg0OSM0MDA4ODMxNTQjMjAwMjM5NA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Novozymes acquires data science platform of Biota to strengthen microbiome R&amp;D capabilities in probiotic development","datePublished":"2021-03-11T16:59:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/"},"wordCount":830,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ2MTg0OSM0MDA4ODMxNTQjMjAwMjM5NA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/","name":"Novozymes acquires data science platform of Biota to strengthen microbiome R&amp;D capabilities in probiotic development - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ2MTg0OSM0MDA4ODMxNTQjMjAwMjM5NA==","datePublished":"2021-03-11T16:59:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ2MTg0OSM0MDA4ODMxNTQjMjAwMjM5NA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ2MTg0OSM0MDA4ODMxNTQjMjAwMjM5NA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novozymes-acquires-data-science-platform-of-biota-to-strengthen-microbiome-rd-capabilities-in-probiotic-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Novozymes acquires data science platform of Biota to strengthen microbiome R&amp;D capabilities in probiotic development"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456181","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=456181"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456181\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=456181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=456181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=456181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}